APA

de Vos S., Swinnen L. J., Wang D., Reid E., Fowler N., Cordero J., Dunbar M., Enschede S. H., Nolan C., Petrich A. M., Ross J. A., Salem A. H., Verdugo M., Agarwal S., Zhou L., Kozloff M., Nastoupil L. J. & Flowers C. R. (20191223). Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

de Vos S, Swinnen L J, Wang D, Reid E, Fowler N, Cordero J, Dunbar M, Enschede S H, Nolan C, Petrich A M, Ross J A, Salem A H, Verdugo M, Agarwal S, Zhou L, Kozloff M, Nastoupil L J and Flowers C R. 20191223. Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

de Vos S., Swinnen L. J., Wang D., Reid E., Fowler N., Cordero J., Dunbar M., Enschede S. H., Nolan C., Petrich A. M., Ross J. A., Salem A. H., Verdugo M., Agarwal S., Zhou L., Kozloff M., Nastoupil L. J. and Flowers C. R. (20191223). Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

de Vos S, Swinnen L J, Wang D, Reid E, Fowler N, Cordero J, Dunbar M, Enschede S H, Nolan C, Petrich A M, Ross J A, Salem A H, Verdugo M, Agarwal S, Zhou L, Kozloff M, Nastoupil L J and Flowers C R. Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study. : Annals of oncology : official journal of the European Society for Medical Oncology. 20191223.